arch49

EN_01506838_0809

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

special instructions

RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

caption

(FILES) This handout file photo obtained May 26, 2021, courtesy of Merck & Co, Inc. shows capsules of the investigational antiviral pill Molnupiravir. - The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill, Molnupiravir, for high risk adults, a day after a similar pill by Pfizer was given the green light. "Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni. (Photo by Handout / Merck & Co,Inc. / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /Merck & Co,Inc./HANDOUT" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

headline arch49

created date 2021-05-26

credit HANDOUT/AFP/East News

source AFP

byline HANDOUT

original transmission reference AFP_9V747F

weight 1,1MB

size 27cm x 15cm by 300dpi

keywords - Show

2021, 26, A, ADDITIONAL, ADMINISTRATION, ADULTS, ADVERTISING, AFTER, AGAINST, AN, AND, ANTIVIRAL, AS, AUTHORIZATION, AUTHORIZED, BE, BY, CAMPAIGNS, CAN, CAPSULES, CAVAZZONI, CLIENTS, CO, COURTESY, COVID, COVID-19, CREDIT, DAY, DISTRIBUTED, DRUG, EDITORIAL, FDA, FILE, FILES, FOOD, FOR, FORM, GIVEN, GREEN, HANDOUT, HEALTH, HIGH, HORIZONTAL, IN, INC, INVESTIGATIONAL, LIGHT, MANDATORY, MARKETING, MAY, MEDICINE, MERCK, MOLNUPIRAVIR, NO, OBTAINED, OF, ON, OPTION, ORALLY, PATRIZIA, PFIZER, PILL, PROVIDES, RESTRICTED, RISK, SAID, SCIENTIST, SERVICE, SHOWS, SIMILAR, TAKEN, THAT, THE, THIS, THURSDAY, TO, TODAY, TREATMENT, US, USE, VIRUS, WAS,